Circa blood pressure monitors are implemented with AFIB technology, which allows patients to be screened for
AF during blood pressure measurements at home.
Atrial Fibrillation (AF) is the irregularity in the heartbeat rhythm occurring in 5% of the population older than 65 years of age and in 14% among those older than 85 years. AF can cause blood to accumulate in the atria of the heart, clump together, and form blood clots. These blood clots can then migrate through the bloodstream to the brain, where they block the blood vessels, leading to a stroke.
AF mostly doesn’t show any symptom in the patient, making it go undiagnosed. Moreover, in the initial stages AF is very irregular, therefore increasing its chances of going undetected during sporadic visits to the doctor. Early detection of AF followed by adequate treatment can reduce the risk of stroke by 68%.
Increases the risk of stroke
Risk of heart attack
65-years old and older
85-years old and older
Circa uses sophisticated algorithm and technology to allow patients to be screened for AF during blood pressure measurements at home. If AF is detected, the AFIB symbol is displayed. Circa AFIB is the world's only, medically proven technology for blood pressure devices that detects dangerous AF with high accuracy (sensitivity 98%, specificity 92%). The high degree of accuracy has been proven several times in clinical trials and has been recommended by international specialists and physicians.